It is a pharma private limited company based in New Delhi, Delhi, India, established in 2016.
2016 | New Delhi, Delhi, India | ActiveNexgenrx Pharmaceuticals Private Limited, a active private limited company, was established on 27 June 2016 in New Delhi, Delhi, India. Engaging in drug formulation & development within the hospital and medical care sector, it holds CIN: U36994DL2016PTC302167. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.97 Cr and a paid-up capital of ₹1.97 Cr.
It upholds a compliant status. Employing 52 professional, Its leadership includes Mohammad Rashid Hasan (Director), Pankaj Kumar Shrivastwa (Additional Director), Ram Mohan Jha (Additional Director). Past directors included Khushaboo Kumari, Ritesh Srivastava, Sweta Kumari. It holds ₹3.89 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Hindustan Times House,Level 10 K. G Marg Connaught Place, New Delhi, Delhi, 110001.
U36994DL2016PTC302167
302167
27 June 2016
₹1.97 Cr
₹1.97 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Nexgenrx Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mohammad Rashid Hasan | Director | 27 Jun 2016 | Current |
| Pankaj Kumar Shrivastwa | Additional Director | 11 Jul 2019 | Current |
| Ram Mohan Jha | Additional Director | 11 Jul 2019 | Current |
| Ritesh Srivastava | Director | 07 Jan 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jul 2019 | Past |
| Pramod Abcsdd | Director | 28 Jan 2018 | Past |
| Pramod Abcsdd | Director | 01 Jul 2019 | Past |
| Pramod Abcsdd | Director | 01 Oct 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nexgenrx Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1347.7% increase. The company also saw a substantial improvement in profitability, with a 117.5% increase in profit. The company's net worth Soared by an impressive increase of 32.44%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Nexgenrx Pharmaceuticals had a public holding of 67.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹38,907,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Mar 2024 | Sidbi | ₹1.36 Cr | Open |
| 28 Dec 2021 | Sidbi | ₹5.28 M | Open |
| 18 Nov 2020 | Sidbi | ₹2.00 Cr | Open |
Explore comprehensive loan charge details -
Nexgenrx Pharmaceuticals has a workforce of 52 employees as of Apr 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Nexgenrx Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nexgenrx Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Nexgenrx Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Nexgenrx Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
The activity A charge with Sidbi amounted to Rs. 1.36 Cr with Charge ID 100895539 was registered on 20 Mar 2024. was completed.
Progress on A charge with Sidbi amounted to Rs. 0.53 Cr with Charge ID 100515687 was registered on 28 Dec 2021. was documented.
A charge with Sidbi amounted to Rs. 2.00 Cr with Charge ID 100388722 was registered on 18 Nov 2020. was recorded as a recent event.
Pankaj Kumar Shrivastwa was appointed as a Additional Director was appointed as a Additional Director on 11 Jul 2019 & has been associated with this company since 6 years 5 months . was recorded as a recent event.
The CIN of Nexgenrx Pharmaceuticals Private Limited is U36994DL2016PTC302167.
Nexgenrx Pharmaceuticals Private Limited is headquartered at Hindustan Times House,Level 10 K. G Marg Connaught Place, New Delhi, Delhi, 110001.
Nexgenrx Pharmaceuticals Private Limited was incorporated on 27 June 2016.
The current directors of Nexgenrx Pharmaceuticals Private Limited are
The primary industry of Nexgenrx Pharmaceuticals Private Limited is Hospital And Medical Care.
Nexgenrx Pharmaceuticals Private Limited is unlisted.
The authorized capital of Nexgenrx Pharmaceuticals Private Limited is ₹1.97 Cr, and the paid-up capital is ₹1.97 Cr.
The compliance status of Nexgenrx Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX